Clinical trials: Allo-SCT Patients
Hematologic Malignancies
Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets
In the transplant community, there is debate regarding the most appropriate food services for stem cell transplant patients. Recommendations regarding the use of low bacterial diets have been based on theoretical concepts of…
- Trial name
- NCT01687231
- Testing
- Non-neutropenic Diet
- Where
- United States
- Volunteers
- 47 people
- Sponsor
- Duke University
Treatment, Stem Cell Transplantation
Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study
This study is an open-label, multicentric, exploratory, single arm, phase II study of adults who are either more than 60 years old, or are unfit for intensive chemotherapy and allo SCT.
- Trial name
- LAL1408 (NCT01025505)
- Testing
- Nilotinib, Imatinib
- Where
- 35 sites in Italy
- Volunteers
- 40 people
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto